Urologix (ULGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
06-2014 | 06-2013 | 06-2012 | 06-2011 | 06-2010 | |
Sales | 14,235 | 16,590 | 17,027 | 12,571 | 14,771 |
Cost of Goods | 8,142 | 8,407 | 8,645 | 6,030 | 6,569 |
Gross Profit | 6,093 | 8,183 | 8,382 | 6,541 | 8,202 |
Operating Expenses | 13,165 | 12,512 | 13,172 | 10,297 | 11,028 |
Operating Income | -6,930 | -3,922 | -4,145 | -3,726 | -2,257 |
Interest Expense | 693 | 555 | 482 | -1 | 0 |
Other Income | -1 | 199 | -13 | 0 | 0 |
Pre-tax Income | -7,624 | -4,278 | -4,640 | -3,725 | -2,257 |
Income Tax | -16 | 14 | 55 | 8 | -88 |
Net Income Continuous | -7,608 | -4,292 | -4,695 | -3,733 | -2,169 |
Net Income | $-7,608 | $-4,292 | $-4,695 | $-3,733 | $-2,169 |
EPS Basic Total Ops | -0.36 | -0.21 | -0.32 | -0.26 | -0.15 |
EPS Basic Continuous Ops | -0.36 | -0.21 | -0.32 | -0.26 | -0.15 |
EPS Diluted Total Ops | -0.36 | -0.21 | -0.32 | -0.26 | -0.15 |
EPS Diluted Continuous Ops | -0.36 | -0.21 | -0.32 | -0.26 | -0.15 |
EPS Diluted Before Non-Recurring Items | -0.36 | -0.22 | -0.30 | N/A | N/A |
EBITDA(a) | $-6,343 | $-3,248 | $-3,450 | $-3,161 | $-1,464 |